01193nas a2200277 4500000000100000008004100001260001700042653001600059653001200075653003100087653003000118653001100148653002300159653001200182653003200194653002500226653001300251100001400264700001500278245007400293300001100367490000700378050003200385520048400417022001400901 1999 d c1999 Oct-Dec10aClofazimine10aDapsone10aDrug Resistance, Microbial10aDrug Resistance, Multiple10aHumans10aLeprostatic Agents10aleprosy10aMicrobial Sensitivity Tests10aMycobacterium leprae10aRifampin1 aGupta U D1 aKatoch V M00aDrug resistance in leprosy: lessons from past and future perspective. a451-630 v71 aInfolep Library - available3 a

Some recent studies indicate that the problem of drug resistance in leprosy is very much there but the exact picture is not clear. In the emerging scenario with increasing number of new cases with low bacterial load, the conventional in-vivo and most of current in-vitro methods for determination of drug resistance may not help. It is pointed out that newer molecular approaches may be more useful and that it will be important to undertake studies to develop such tools.

 a0254-9395